Mika Skeppholm

Danderyd, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Apixaban trough concentrations in atrial fibrillation patients with reduced renal function.

Apixaban trough concentrations in atrial fibrillation patients with reduced renal function.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 16, 2024

Effects of dabigatran, rivaroxaban, and apixaban on fibrin network permeability, thrombin generation, and fibrinolysis.

Effects of dabigatran, rivaroxaban, and apixaban on fibrin network permeability, thrombin generation, and fibrinolysis.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: July 02, 2024

Apixaban plasma concentrations in patients with obesity.

Apixaban plasma concentrations in patients with obesity.

Journal: European journal of clinical pharmacology

Published: February 08, 2024

Rapid Detection of Apixaban by a ROTEM-Based Approach and Reversibility with Andexanet Alfa or DOAC-Stop.

Rapid Detection of Apixaban by a ROTEM-Based Approach and Reversibility with Andexanet Alfa or DOAC-Stop.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: March 12, 2022

Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.

Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.

Journal: Thrombosis and haemostasis

Published: March 26, 2017

Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment.

Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment.

Journal: Thrombosis research

Published: December 30, 2016

Usefulness of Health Registers for detection of bleeding events in outcome studies.

Usefulness of Health Registers for detection of bleeding events in outcome studies.

Journal: Thrombosis and haemostasis

Published: May 25, 2016

Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.

Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.

Journal: European journal of clinical pharmacology

Published: January 19, 2016

Clinical evaluation of laboratory methods to monitor apixaban treatment in patients with atrial fibrillation.

Clinical evaluation of laboratory methods to monitor apixaban treatment in patients with atrial fibrillation.

Journal: Thrombosis research

Published: March 10, 2015

Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.

Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.

Journal: Journal of the American College of Cardiology

Published: July 03, 2014

On the monitoring of dabigatran treatment in "real life" patients with atrial fibrillation.

On the monitoring of dabigatran treatment in "real life" patients with atrial fibrillation.

Journal: Thrombosis research

Published: March 04, 2014

Adherence to warfarin treatment among patients with atrial fibrillation.

Adherence to warfarin treatment among patients with atrial fibrillation.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: January 23, 2014

Showing 1-12 of 19

Last Updated: 09/26/2026